Sorrel™ Platform – A next generation on body delivery system (OBDS) for large volume and highly viscous formulations

Designed with both patient and pharma in mind, the Sorrel OBDS wearable platform is digitally integrated to deliver greater data for the pharma eco-system and enable better adherence for the patient.

Based on our patents and ground-breaking design, Sorrel™is suited for multiple configurations, molecules, and indications to enable smart, reliable, simple drug delivery at home.

Intuitive for the patient, our platform enables pharma partners to mitigate the risks associated with original development including safety, efficacy, cost and time to market.

Key benefits for pharmaceutical partners

Sorrel Device

  • Connectivity function to deliver product improvement and compliance data

  • Wide range of volumes available from 1mL to 50+ mL

  • Primary-container agnostic to fits seamlessly into established filling processes

  • Software-controlled for unlimited infusion profiles

  • Platform design reduces development time and cost, while enabling customer flexibility in development

  • Novel UV disinfection at point-of-care simplifies loading of primary container

  • Electromechanical ‘pulling’ of drug protects sensitive biologics

Key benefits for patients

  • Designed to optimise patient experience and improve regimen adherence

  • Pre-filled and pre-loaded to make use easier for the user, simply peel, stick, initiate

  • No patient handling of needles nor drug

  • Reassurance in successful and safe administration enabled by tactile, audio, and visual smart indicators

  • Virtually-painless needle deployment for enhanced user-experience